Patients satisfied with oral sedation for cataract surgery

(HealthDay)—Using oral sedation during cataract surgery does not negatively impact patient satisfaction compared with using an intravenous (IV) sedative, according to a study published online April 16 in Ophthalmology.

Crandall E. Peeler, M.D., from Boston Medical Center, and colleagues randomly assigned 85 patients (mean age, 65.8 years) scheduled for cataract surgery to receive either oral triazolam with IV placebo or IV midazolam with oral placebo preoperatively.

The researchers found that the mean score was 5.34 (range, 3.75 to 6) in the oral group and 5.4 (range, 4 to 6) in the IV group. Given the a priori noninferiority margin of 0.5, the actual difference of 0.06 between the groups demonstrated noninferiority of oral sedation (P = 0.0004). Surgeons and anesthesia providers reported similar satisfaction in the two groups. In the oral group, intraoperative complications occurred in 16.7 percent of patients compared with 9.3 percent in the IV group (P = 0.31). Supplemental IV sedation was used in eight patients in the oral group and three in the IV group (P = 0.097).

"The use of oral sedation in has been suggested as a cost- and space-saving measure, potentially allowing the transition of some cases from an operating to procedure room or office-based setting," the authors write.

Explore further

Naltrexone implant helps HIV patients prevent opioid relapse

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: Ophthalmology

Copyright © 2019 HealthDay. All rights reserved.

Citation: Patients satisfied with oral sedation for cataract surgery (2019, May 2) retrieved 21 October 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments